Finance entity

Eventide Asset Management LLC

Company

All 1 tracked stories fall under one category: markets. Collegium Pharmaceutical, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.2 for that window.

Last mentioned: Mar 15, 2026

Entity pulse

Recent coverage · Eventide Asset Management LLC

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Eventide Asset Management LLC

All 1 tracked stories fall under one category: markets. Collegium Pharmaceutical, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.2 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. We currently track 1 Finance story that mention Eventide Asset Management LLC, all published on March 15, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 82 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Eventide Asset Management LLC. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Eventide Rebalancing

    Eventide Asset Management reports a reduced but significant stake of $83.65 million in Collegium.

  2. Institutional Reduction

    Integrated Quantitative Investments LLC reduces its stock position in COLL.

  3. Truist Analysis

    Truist Securities highlights momentum for Jornay PM and a robust pain portfolio.

  4. BDSI Acquisition

    Collegium completes the acquisition of BioDelivery Sciences International, adding Belbuca to its portfolio.

Stories mentioning Eventide Asset Management LLC 1

Markets Neutral

Eventide Asset Management Trims Stake in Collegium Pharmaceutical to $83.6M

Eventide Asset Management LLC has reduced its equity position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant $83.65 million stake. This institutional shift comes as the specialty pharmaceutical firm navigates a shifting landscape for chronic pain management and expands into neurology.

2 sources

Eventide Asset Management LLC is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.